Sign up to save your podcasts
Or
Share Giving pathologists AI-superpowers with Tenomix's co-founder Saumik Biswas
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Giving pathologists AI-superpowers with Tenomix's co-founder Saumik Biswas
Is the AI hype cycle bringing you down? Don’t worry—we’re here with an episode of the podcast that will inspire new hope for AI being used for more than just removing people from holiday snaps.
On this very special episode of Tech About Town, Saumik Biswas joined us in the studio to share how his startup aims to improve cancer patient outcomes with the collab you didn’t know we needed—AI, robotics and ultrasound. Saumik co-founded Tenomix, a life science startup that has developed a solution to improve the reliability and speed of cancerous lymph node detection in pathology labs.
This episode has everything, with Saumik sharing his thoughts on the broader implications of AI in healthcare, the power infrastructure required for advanced AI and the unique challenges of med-tech entrepreneurship, from funding to regulatory compliance.
Don’t forget to leave us a comment (if you’re using the Spotify app) to let us know what you think.
Timestamps:
0:00 – Alex and Sacha catch up on their Oktoberfest experiences and chat about local children’s entertainer Eric Traplin.
1:10 – Meet Saumik Biswas, founder of Tenomix, who explains how AI and robotics can supercharge pathology.
2:03 – Saumik recounts personal stories that inspired his work in pathology, including his brother’s rare bone condition and his aunt’s battle with cancer.
4:42 – The impact of Saumik’s experiences on his passion for medical innovation and understanding disease mechanisms.
5:45 – How Tenomix aims to solve critical issues in pathology.
12:56 – The challenges pathology labs face and how Tenomix aims to streamline lab processes.
15:10 – The importance of ecosystem support and mentorship in med-tech development.
17:45 – Saumik discusses fundraising challenges and the role of trust in securing investments.
23:02 – The power requirements for AI and the move toward nuclear energy to sustain large-scale AI applications.
31:36 – The critical role of partnerships with hospitals for clinical validation.
View all episodes
By CommunitechIs the AI hype cycle bringing you down? Don’t worry—we’re here with an episode of the podcast that will inspire new hope for AI being used for more than just removing people from holiday snaps.
On this very special episode of Tech About Town, Saumik Biswas joined us in the studio to share how his startup aims to improve cancer patient outcomes with the collab you didn’t know we needed—AI, robotics and ultrasound. Saumik co-founded Tenomix, a life science startup that has developed a solution to improve the reliability and speed of cancerous lymph node detection in pathology labs.
This episode has everything, with Saumik sharing his thoughts on the broader implications of AI in healthcare, the power infrastructure required for advanced AI and the unique challenges of med-tech entrepreneurship, from funding to regulatory compliance.
Don’t forget to leave us a comment (if you’re using the Spotify app) to let us know what you think.
Timestamps:
0:00 – Alex and Sacha catch up on their Oktoberfest experiences and chat about local children’s entertainer Eric Traplin.
1:10 – Meet Saumik Biswas, founder of Tenomix, who explains how AI and robotics can supercharge pathology.
2:03 – Saumik recounts personal stories that inspired his work in pathology, including his brother’s rare bone condition and his aunt’s battle with cancer.
4:42 – The impact of Saumik’s experiences on his passion for medical innovation and understanding disease mechanisms.
5:45 – How Tenomix aims to solve critical issues in pathology.
12:56 – The challenges pathology labs face and how Tenomix aims to streamline lab processes.
15:10 – The importance of ecosystem support and mentorship in med-tech development.
17:45 – Saumik discusses fundraising challenges and the role of trust in securing investments.
23:02 – The power requirements for AI and the move toward nuclear energy to sustain large-scale AI applications.
31:36 – The critical role of partnerships with hospitals for clinical validation.